Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
03/2003
03/06/2003WO2003018767A2 Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
03/06/2003WO2003018752A2 An organotypic intestinal culture and methods of use thereof
03/06/2003WO2003018743A2 Emu-based formulations for wound treatment
03/06/2003WO2003018077A1 Method of bone regeneration
03/06/2003WO2003018069A1 Preparation and diabetic use of gibberellins
03/06/2003WO2003018049A2 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
03/06/2003WO2003018041A1 Method of treating spinal injury and remedy therefor
03/06/2003WO2003018040A1 Composite graft for treatment of retinal diseases
03/06/2003WO2003018039A1 Pharmaceutical ingredient for medical treatment and preventing of cancer
03/06/2003WO2003017992A2 Means for treatment of atherosclerosis
03/06/2003WO2003017920A2 Protective factors against inflammation, burns and noxious stimuli
03/06/2003WO2003017913A1 Compositions, methods and apparatus for surgical procedures
03/06/2003WO2003002131B1 Strain of micro-organism lactobacillus fermentum me-3 as novel anti-microbial and antioxidative probiotic
03/06/2003WO2002101021A3 Purification of human serum albumin
03/06/2003WO2002095026A8 Method of proliferating terminal differentiated cells and recombinant vector therefor
03/06/2003WO2002092122A3 Use of osteopontin for the treatment and/or prevention of neurologic diseases
03/06/2003WO2002088337B1 Olfactory ensheathing glia produced by introducing telomerase
03/06/2003WO2002074243A9 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
03/06/2003WO2002066511A3 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
03/06/2003WO2002051994A8 Polypeptides
03/06/2003WO2002022080A9 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
03/06/2003WO2002012325A3 Suppressor gene
03/06/2003WO2002012281A9 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
03/06/2003WO2001074900A9 Nuclear factor kb inducing factor
03/06/2003WO2001055393A9 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
03/06/2003US20030045943 Device for regeneration of articular cartilage and other tissue
03/06/2003US20030045498 Contacting the ocular cell with an expression vector comprising the nucleic acid sequence encoding the inhibitor of angiogenesis and the nucleic acid sequence encoding the neurotrophic agent.
03/06/2003US20030045468 Polypeptide comprising at least 7 consecutive amino acid residues of human mammaglobin, wherein no more than 30 consecutive residues of human mammaglobin are present
03/06/2003US20030044978 Expanded and genetically modified populations of human hematopoietic stem cells
03/06/2003US20030044813 Diagnosing cancer in humans; obtain tissue, incubate with marker agent, detect signal, evaluate for cancer
03/06/2003US20030044773 Genetically engineering viral polypeptide; obtain nucleotide sequences coding polypeptide, insert codon, clone into vector, transform cell, detect expression of genetically engineered polypeptide
03/06/2003US20030044765 Use of cytokines and mitogens to inhibit pathological immune responses
03/06/2003US20030044470 Mussel hydrolysate from Indian green mussel (Perna viridis) and at least one additive; method of extraction; inhibition of receptor activator of NF-KB ligand (RANKL)
03/06/2003US20030044468 Shaping polymeric precursors by inducing thermal gelation of an aqueous solution thereof and then curing said precursors by crosslinking reactive groups; biomedical uses include drug delivery, microencapsulation, implantation
03/06/2003US20030044397 In digestable carrier; therapy for liver disorders
03/06/2003US20030044396 Tissue engineering; generating thymus tissue
03/06/2003US20030044391 Preparation and xenotransplantation of porcine islets
03/06/2003US20030044390 Applying stresses to blood sampling
03/06/2003US20030044387 Liver cancer therapy
03/06/2003US20030044386 Genetic engineering; nucleic acid coding cytokines
03/06/2003US20030044385 Antitumor, anticancer agents
03/06/2003US20030044384 Treatment of neoplasms with viruses
03/06/2003US20030044383 Tissue specific adenoviral vectors
03/06/2003US20030044381 Synthetic soil-extract materials and medicaments for influenza viruses based thereon
03/06/2003US20030042435 Quartz schist comprising oxides of silicon, aluminum, and iron
03/06/2003US20030042201 Supplying drinking water in situ
03/06/2003US20030041386 Graft prosthesis, materials and methods
03/06/2003CA2459974A1 Emu-based formulations for wound treatment related application information
03/06/2003CA2458753A1 Compositions, methods and apparatus for surgical procedures
03/06/2003CA2458362A1 Isolation of inner cell mass for the establishment of human embryonic stem cell (hesc) lines
03/06/2003CA2458261A1 Differentiation of neural stem cells and therapeutic use thereof
03/06/2003CA2458226A1 Improved nitroreductase enzymes
03/05/2003EP1288299A2 TRNA synthetase
03/05/2003EP1288291A1 Method of amplifying natural killer t cells
03/05/2003EP1287362A2 Compositions and methods for modulating tumor specific expression
03/05/2003EP1287120A2 Human circulating dendritic cell compositions and methods
03/05/2003EP1287116A2 Neural progenitor cell populations
03/05/2003EP1287115A2 Retinal pigment epithelial cell lines with extended life-span and their applications
03/05/2003EP1287034A2 Derivatives of breast cancer antigen her-2 for therapeutical use
03/05/2003EP1287029A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/05/2003EP1287028A2 Compositions and methods for the therapy and diagnosis of colon cancer
03/05/2003EP1287025A1 Sheep lice, bovicola ovis, allergen treatment
03/05/2003EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents
03/05/2003EP1287019A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
03/05/2003EP1287004A1 Synthetic process for the manufacture of an ecteinascidin compound
03/05/2003EP1286708A1 Method for producing a bio-artificial transplant
03/05/2003EP1286703A2 Methods and compounds for controlled release of recombinant parvovirus vectors
03/05/2003EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
03/05/2003EP1286689A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
03/05/2003EP1286688A2 A method of treatment of alzheimer's disease with a protein extractable from mammalian organs
03/05/2003EP1286687A2 A method of treatment of huntington's chorea with a protein extractable from mammalian organs
03/05/2003EP1286685A2 A method of treatment of parkinson's disease with a protein extractable from mammalian organs
03/05/2003EP1286683A2 A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
03/05/2003EP1286678A2 Combination of a mutant herpes virus and a chemotherapeutic agent for the treatment of cancer
03/05/2003EP1286677A1 Purified material having size and growth inhibitory effects on cells and tissues
03/05/2003EP1286652A2 Skin protectant spray compositions
03/05/2003EP1163004B1 Immunoadsorber for use in sepsis therapy
03/05/2003EP0877795A4 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use
03/05/2003EP0845034B1 peptide having pronociceptive properties
03/05/2003EP0822824A4 Method of pretreating viable tissue or cells to be contained within a semipermeable vessel
03/05/2003EP0804254B1 Heat treated blood plasma proteins
03/05/2003EP0554352B1 A method for transplanting cells into the brain and therapeutic uses therefor
03/05/2003CN2538241Y Electric chafing dish with medical stone
03/05/2003CN1400906A Treatment of congestive heart failure by pretreated autologous blood
03/05/2003CN1400871A Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability of undesired permeability of the
03/05/2003CN1400008A Medicine for curing nasal sinusitis
03/05/2003CN1400007A Oral Chinese medicine for curing osteoarthropathy
03/05/2003CN1400005A Chinese medicine for boosting brain and supplementing kidney and its preparation method
03/05/2003CN1400004A Chinese medicine preparation for curing chronic conjunctivitis
03/05/2003CN1399999A Medicine for curing malignant turnor and its preparation method
03/05/2003CN1399986A Medicine for curing sleepless
03/05/2003CN1399979A Chinese medicine composition for curing cancers
03/05/2003CN1399977A Medicine for curing prolapse of lumbar intervertebral disc and its preparation method
03/05/2003CN1399976A Chinese medicine powder preparation for resisting thrombosis and its preparation method
03/05/2003CN1399975A Medicine for curing peptic ulcer and its preparation method
03/05/2003CN1399971A Biological preparation for curing burn and its preparation method
03/05/2003CN1399970A Preparation method of silkworm dropping soluble preparation
03/05/2003CN1399969A Production method of health-care food with auxiliary action for curing diabetos
03/05/2003CN1399968A Health-care food and its production method
03/05/2003CN1399967A Wound healing ointment